Scholars Central

Conference abstract

Bioequivalence studies of highly variable drugs: Case studies

Authors: Shamkant L. Shimpi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bioequivalence studies are performed to demonstrate in vivo that two pharmaceutically products are comparable in their rate and extent of absorption. Concerns have been expressed increasingly regarding the difficulty for highly variable drugs and drug products (%CV greater than 30) to meet the standard bioequivalence (BE) criteria using a reasonable number of study subjects. The most important feature of SABE is that a fixed sample size is adequate to demonstrate bioequivalence regardless of within-subject variability. One of the approach is scaling an average BE criterion to the within-subject variability of the reference product in a crossover BE study, together with a point-estimate constraint imposed on the geometric mean ratio between the test and reference products. This involves determination of variability of the reference product, which requires replication of the reference treatment in each individual. Case Study: Atazanavir Sulfate Capsules- The BE recommendation by US FDA for Atazanavir Sulfate Capsules is two way, cross over, in vivo study with 300 mg strength in both fasting and fed condition. The dosage and administration states that Reyataz must be taken with food. Further the recommended dosages are 400 mg Atazanavir daily once or 300 mg Atazanavir with 100 mg Retonavir. So based on the information, the BE study recommendation should be revised as ? Only Fed study with 300 mg Atazanavir ? Bioequivalence study with 400 mg Atazanavir (Two 200 mg capsules) with food ? Bioequivalence study with 300 mg Atazanavir + 100 mg Ritonavir (Norvir)

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Shamkant L. Shimpi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels